Arcturus Therapeutics Holdings Inc Stock Performance
as on May 13, 2026 at 6:59 am IST
Day's Low
Day's High
$8.18$8.96
0.85%
Downside
8.61%
Upside
52 Week's Low
52 Week's High
$5.85$24.1729.09%
Downside
192.97%
Upside
Arcturus Therapeutics Holdings Inc share price movements today
- Previous Close
- $8.63
- Open
- $8.54
- Volume
- 745.0K
- Day's Low - High
- $8.18 - $8.96
- 52 Week Low - High
- $5.85 - $24.17
Arcturus Therapeutics Holdings Inc Historical Returns
- 1 Month Return
- + 3.29 %
- 3 Month Return
- + 20.43 %
- 1 Year Return
- -25.5 %
- 3 Year Return
- -71.76 %
- 5 Year Return
- -67.17 %
Arcturus Therapeutics Holdings Inc Stock Fundamentals & Key Indicators
Check Arcturus Therapeutics Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$262.1M
EPS (TTM)
-4.0254
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-85.5M
Revenue (TTM)
54.7M
Profit Margin
-143.80%
Return On Equity TTM
-37.01%
Arcturus Therapeutics Holdings Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Arcturus Therapeutics Holdings Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $262.1M | -67.17% | NA | -143.80% | |
| BUY | $39.4B | 113.59% | 74.13 | 12.55% | |
| NA | $32.2B | NA | 70.46 | 8.94% | |
| BUY | $109.1B | 104.61% | 25.51 | 35.51% | |
| BUY | $74.9B | 40.55% | 17.45 | 29.65% |
Stock Returns calculator for Arcturus Therapeutics Holdings Inc Stock including INR - Dollar returns
The Arcturus Therapeutics Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Arcturus Therapeutics Holdings Inc investment value today
Current value as on today
₹80,183
Returns
Returns from Arcturus Therapeutics Holdings Inc Stock
Dollar Impact
₹9,001 (+9%)
Analyst Recommendation on Arcturus Therapeutics Holdings Inc Stock
Based on 16 analysts
87.50%
Buy
6.25%
Hold
6.25%
Sell
Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Arcturus Therapeutics Holdings Inc. Average target price of $23.2
Arcturus Therapeutics Holdings Inc Share Price Target
Get share price movements and forecasts by analysts on Arcturus Therapeutics Holdings Inc.
What analysts predicted
64.44%UPSIDE
Target Price
$23.2
Current Price
$8.25
Analyzed by
16 Analysts
Target
$23.20
Arcturus Therapeutics Holdings Inc target price $23.2, a slight upside of 64.44% compared to current price of $8.25. According to 16 analysts rating.
Indian Investors' Interest in Arcturus Therapeutics Holdings Inc Stock
Search interest for Arcturus Therapeutics Holdings Inc Stock has increased by 92% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:92% versus previous 30 day period
Arcturus Therapeutics Holdings Inc Quarterly Profit & Loss
All numbers in Millions USD
Arcturus Therapeutics Holdings Inc Annual Profit & Loss
All numbers in Millions USD
Arcturus Therapeutics Holdings Inc Quarterly Cash Flow
All numbers in Millions USD
Arcturus Therapeutics Holdings Inc Annual Cash Flow
All numbers in Millions USD
Arcturus Therapeutics Holdings Inc News & Key Events
Today's Timeline - 22 October
Wed, 05:25 PM
-Arcturus Therapeutics announces interim Phase 2 results for ARCT-032, showing it was generally safe and well tolerated.
Wed, 06:57 PM
-ARCT stock declines after interim Phase 2 trial results show no meaningful improvement in FEV values for ARCT-032.
Thu, 00:35 AM
-ARCT stock drops 56.30% after mixed Phase 2 trial results for ARCT-032, indicating no significant lung function improvement.
Insights on Arcturus Therapeutics Holdings Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 3 months, ARCT stock has moved up by 20.4%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -29.07M → 1.93M (in $), with an average increase of 1605.1% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 30.4% return, outperforming this stock by 102.2%
- NO EFFECT
Against Peers
In the last 1 year, BeOne Medicines Ltd has given 33.2% return, outperforming this stock by 58.7%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 5 quarters, 29.38M → 2.06M (in $), with an average decrease of 40.4% per quarter
About Arcturus Therapeutics Holdings Inc
| Organisation | Arcturus Therapeutics Holdings Inc |
| Headquarters | 10285 Science Center Drive, San Diego, CA, United States, 92121 |
| Industry | Biotechnology |
| CEO | Mr. Joseph E. Payne M.Sc. |
| E-voting on shares | Click here to vote |
Key Management of Arcturus Therapeutics Holdings Inc
Name | Title |
|---|---|
Ms. Natasha O. Bowman | Chief Human Resources Officer |
Dr. Igor Smolenov M.D., Ph.D. | Chief Development Officer |
Dr. Ye Zhang | Chief Regulatory & Quality Assurance Officer |
Dr. Padmanabh Chivukula Ph.D. | Founder, Chief Scientific Officer, COO & Secretary |
Mr. Lance Kurata | Chief Legal Officer |
Ms. Neda Safarzadeh | Vice President and Head of IR/PR & Marketing |
Dr. Alan H. Cohen FAAAAI, FAAP, FACAAI, FCCP, M.D. | Chief Medical Officer |
Mr. Joseph E. Payne M.Sc. | Founder, President, CEO & Director |
Mr. Joseph Roberts | Principal Financial & Accounting Officer and Controller |
Mr. Kevin T. Skol | Chief Business Officer |
FAQs
What is Arcturus Therapeutics Holdings Inc share price today?
Arcturus Therapeutics Holdings Inc share price today is $8.25 as on at the close of the market. Arcturus Therapeutics Holdings Inc share today touched a day high of $8.96 and a low of $8.18.
What is the 52 week high and 52 week low for Arcturus Therapeutics Holdings Inc share?
Arcturus Therapeutics Holdings Inc share touched a 52 week high of $24.17 on and a 52 week low of $5.85 on . Arcturus Therapeutics Holdings Inc stock price today i.e. is closed at $8.25,which is 65.87% down from its 52 week high and 41.03% up from its 52 week low.
What is Arcturus Therapeutics Holdings Inc's market capitalisation today?
Arcturus Therapeutics Holdings Inc market capitalisation is $0.00T as on .
How to invest in Arcturus Therapeutics Holdings Inc Stock (ARCT) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Arcturus Therapeutics Holdings Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Arcturus Therapeutics Holdings Inc Shares that will get you 0.1818 shares as per Arcturus Therapeutics Holdings Inc share price of $8.25 per share as on May 13, 2026 at 1:29 am IST.
What is the minimum amount required to buy Arcturus Therapeutics Holdings Inc Stock (ARCT) from India?
Indian investors can start investing in Arcturus Therapeutics Holdings Inc (ARCT) shares with as little as ₹95.618 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.18 in Arcturus Therapeutics Holdings Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Arcturus Therapeutics Holdings Inc share’s latest price of $8.25 as on May 13, 2026 at 1:29 am IST, you will get 1.2121 shares of Arcturus Therapeutics Holdings Inc. Learn more about
fractional shares .
What are the returns that Arcturus Therapeutics Holdings Inc has given to Indian investors in the last 5 years?
Arcturus Therapeutics Holdings Inc stock has given -67.17% share price returns and 29.61% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?